Efficacy and Safety of the Low-molecular Heparin in Treatment and Prevention of the Acute Coronary Syndrome
Introduction. For a long time, the main medication for treating and preventing of thrombotic complications was unfractionated heparin (UFH). However, despite its high efficiency, UFH has a number of disadvantages and side effects. Significant advantages over UFH are low molecular weight heparins or...
Saved in:
| Main Authors: | Katerenchuk I., Tsyhanenko I., Katerenchuk O. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Publishing House "Kyrylytsya"
2013-03-01
|
| Series: | Львівський клінічний вісник |
| Subjects: | |
| Online Access: | http://lkv.biz/efficacy-and-safety-of-the-low-molecular-heparin-in-treatment-and-prevention-of-the-acute-coronary-syndrome/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The methods of assessment of quality and safety of medicaments on the basis of low molecular weight heparins
by: E. A. Arianova, et al.
Published: (2011-09-01) -
Influence of low molecular weight heparin on cancer patients’ survival
by: V. V. Ptushkin
Published: (2014-07-01) -
Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital
by: A. S. Kolbin, et al.
Published: (2015-03-01) -
Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01) -
VENOUS THROMBOEMBOLISM IN RELATION TO OVARIAN HYPERSTIMULATION SYNDROME: AN APPROACH TO DETERMINING THE LOW-MOLECULAR-WEIGHT-HEPARIN DOSES AND ACTIVITY
by: I. E. Zazerskaya, et al.
Published: (2016-06-01)